Bio Protocol BIO

▼ +96.14% from ATH

The AI data angle works like this: once IP-NFTs are aggregated inside a bioDAO treasury, the DAO can license access to those datasets to AI companies under terms voted on by token holders. Revenue flows back into the treasury. The promise is a feedback loop where data licensing revenue funds more research, which creates more IP-NFTs, which attract more AI buyers.

BIO tokenomics and DeSci ecosystem

BIO launched with a total supply of 3.35 billion tokens. Allocation includes ecosystem/DAO treasury, team (with vesting), investors, and community incentives including airdrops to existing VitaDAO and HairDAO participants who had demonstrated engagement before BIO launched. The investor base—Pfizer Ventures, a16z crypto, Shine Capital—is notable because it includes traditional life sciences capital alongside crypto-native funds, which is unusual and relevant to the thesis.

Key ecosystem bioDAOs at launch:

• VitaDAO — longevity research, one of the oldest and largest DeSci DAOs with published research and real IP portfolios.
• HairDAO — alopecia and hair loss research, funded multiple academic labs.
• AthenaDAO — women's reproductive health.
• PsyDAO — psychedelic-assisted therapy research.
• ValleyDAO — synthetic biology for climate tech.

Bio Protocol vs VitaDAO: how they relate

VitaDAO is the oldest and best-known DeSci project, founded in 2021. It focuses specifically on longevity research and has its own token, VITA. Bio Protocol is not a competitor to VitaDAO—it is the shared infrastructure layer that VitaDAO (and other bioDAOs) plugs into. Think of Bio Protocol as the TCP/IP layer and VitaDAO as an application built on top.

BIO holders can participate in governance across all bioDAOs in the ecosystem, while VITA holders govern only the VitaDAO-specific portfolio. For investors, BIO offers broader exposure to the DeSci sector with less concentration in any single disease area.

For AI-adjacent tokens in the same cycle, see Fetch.ai price and our exchange ratings for trading venue comparison.

AI and biotech data labeling on-chain

The data labeling vertical is where Bio Protocol's AI narrative becomes concrete. Biological data—genomic sequences, protein structures, pathology images, clinical trial outputs—requires expert annotation before it is useful for training AI models. Annotating one genomic dataset can cost millions of dollars if routed through traditional CROs (contract research organizations).

Bio Protocol's roadmap includes a marketplace where researchers and bioDAOs can post labeling tasks, and contributors—domain-expert crowds or AI-assisted tools—earn BIO for verified annotations. That connects the token to a real workflow with real costs that pharma and biotech companies currently pay to centralized vendors.

How to buy Bio Protocol (BIO)

1. Select an exchange that lists BIO. Binance, OKX, Bybit, and Gate.io are the primary venues. Our exchange ratings compare fees, security, and geographic availability.
2. Complete KYC and fund your account. USDT deposits settle fastest. For self-custody, set up a MetaMask or Rabby wallet before withdrawing.
3. Execute the trade. BIO/USDT pairs carry the most liquidity. Limit orders minimize slippage during low-volume hours.
4. Consider where BIO lives on-chain. The token exists on Ethereum mainnet and Base. Gas fees on mainnet favor larger trade sizes; Base is cheaper for smaller amounts.
5. If you plan to participate in bioDAO governance, move BIO to a self-custody wallet and familiarize yourself with snapshot.org voting tools used by the ecosystem.

For longer-range price targets tied to DeSci adoption milestones, see the Bio Protocol price forecast.

Risks of holding Bio Protocol

BIO is a small-cap token at the intersection of two early-stage sectors. The risks compound.

• Research timeline risk. Drug discovery takes 10-15 years even under ideal conditions. Token prices price in success years before it happens. Most IP funded by bioDAOs will not produce commercial returns in a typical crypto investment horizon.
• Regulatory uncertainty for IP-NFTs. Tokenized intellectual property is legally novel in most jurisdictions. Enforcement of IP-NFT rights in traditional courts has not been tested at scale.
• Pharma partnership execution. BIO is priced partly on the thesis that big pharma will license data from bioDAOs. Actual deals are slow and subject to procurement rules, legal review, and data-room standards that DAOs are still learning to meet.
• DeSci narrative dependency. Like other niche-narrative tokens, BIO can trade 80%+ below peak when the sector falls out of rotation, regardless of research progress. Compare to AI token volatility for reference.
• Liquidity risk. BIO is a small-cap token with relatively thin order books outside the top one or two venues. Large exits can move price materially.
• Team and investor unlock schedules. Track vesting calendars for team and investor allocations before entering a large position.

This page is information, not financial advice. Consult a licensed professional before investing.

Bio Protocol price analysis

At the time of writing, Bio Protocol (BIO) trades at $0.034245, with a 24-hour trading volume of $15.07M and a total market capitalization of $73.53M. The asset is currently ranked #372 among all tracked cryptocurrencies by market cap.

Over the last 24 hours, the BIO price has rose +1.76%. On the seven-day chart, Bio Protocol has retraced +15.24%, showing mixed signals across the short and medium term. Short-term price swings are often amplified by liquidity conditions, news flow, and derivatives positioning, so traders should confirm signals across multiple indicators before acting.

Bio Protocol's all-time high of $0.888995 was set on January 3, 2025. The current market price is +96.14% below that historical peak. Distance from the all-time high is a common reference point when evaluating long-term recoveries and identifying macro support or resistance levels.

How to buy Bio Protocol

Buying Bio Protocol (BIO) is straightforward once you know which exchange to use and which trading pair offers the best liquidity. The steps below describe the typical flow used by most investors today.

1. Choose a reputable exchange. Pick a platform that lists BIO with deep liquidity, transparent fees, and strong security practices. Our top-rated exchanges guide compares the leading venues side-by-side.
2. Create and verify your account.Complete the exchange's KYC process — most platforms require a government-issued ID and a short identity check. Verification is usually a one-time step that takes just a few minutes.
3. Deposit funds. Fund your account with fiat currency via bank transfer, card, or a stablecoin like USDT or USDC. Stablecoin deposits typically offer the fastest settlement and lowest fees.
4. Place a buy order. Navigate to the BIO/USD or BIO/USDT pair and either execute a market order for instant fills or set a limit order at your preferred entry price.
5. Secure your BIO. For long-term holdings, consider moving your tokens to a non-custodial wallet — a hardware device for the highest security, or a reputable software wallet for frequent access.

You can also use the built-in Bio Protocol converter above to estimate exactly how much BIO you would receive for a given amount in USD before placing an order.

Is Bio Protocol a good investment?

Whether Bio Protocol is a good investment depends on your goals, time horizon, and tolerance for volatility. Like all cryptocurrencies, BIO carries significant market risk — prices can rise or fall sharply in a single day, and past performance is not a reliable indicator of future returns.

Potential strengths

• Ranked #372 by market cap with an established trading history and active exchange coverage.
• Transparent on-chain data: real-time supply, circulation metrics, and publicly auditable transactions.
• Ongoing ecosystem development and community engagement, as reflected in BNB Chain Ecosystem, Binance Launchpool sector activity.

Key risks to consider

• Volatility: 24-hour moves of 5–15% are common in crypto markets.
• Regulatory uncertainty: changes in policy across major jurisdictions can materially affect price and access.
• Liquidity and custody risk: not all exchanges are equally safe, and self-custody requires careful key management.

This page provides data and analysis for educational purposes only. It is not financial advice. Always do your own research, diversify, and never invest more than you can afford to lose.